We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
iCAD, a provider of Computer-Aided Detection (CAD) solutions for the early identification
of cancer, announced Mamassist has joined its reseller channel.
CardioDynamics, a company dealing in impedance cardiography (ICG) technology,
announced the results of its multicenter, randomized study called CONTROL (Efficacy
Of Noninvasive Hemodynamic Monitoring To Target Reduction Of Blood Pressure
Levels).
Applied Biosystems Group, an Applera business, together
with its joint venture partner MDS Sciex, a division of MDS, announced the introduction
of the Applied Biosystems/ MDS Sciex 4800 MALDI TOF/TOF Analyzer, the most sensitive
MALDI TOF/TOF mass spectrometer for identifying and quantifying protein biomarkers.
BioCardia has released the Morph 6 French Universal Deflectable Guide Catheter,
based on catheter technology that provides the ability to change shape to navigate
within anatomy.
The LifeShirt System from VivoMetrics will be used in a multisite clinical trial
supported by the Cystic Fibrosis Foundation to measure and gather data on the
breathing patterns of children with cystic fibrosis (CF) between the ages of
3 and 6 years.
Medtronic announced the U.S. commercial introduction of the Cardioblate BP2
Surgical Ablation System, which offers cardiac surgeons new ease and flexibility
in creating ablation lines during open heart procedures, including the "Maze
III" procedure.
Biophan Technologies has executed a letter of intent (LOI) with German biomedical
researchers Arno Bucker and Alexander Ruebben for an exclusive license to their
breakthrough cardiovascular stent technology enabling accurate magnetic resonance
imaging (MRI) angiography of the interior of vascular stents.
Mediscience Technology announced that its wholly owned New York subsidiary,
Medi-Photonics Development, has requested a formal meeting with the FDA to discuss
the CD-Ratiometer, an optical biopsy device as an adjunct to diagnosis for cancer
detection of the cervix and other abnormalities.
DexCom announced it has received notification from the FDA that its PMA (premarket
approval application) for the DexCom Short-Term Continuous Glucose Sensor submitted
in March 2005 has been accepted as filed and granted expedited review status.
Biophan Technologies, a developer of next-generation medical technology, announced
that its proprietary advanced solutions in the field of MRI safety present a
range of potential solutions to serious safety risks associated with the use
of MRI imaging of patients with implanted medical devices that have been widely
reported in the media.